Therapies Offered at Residential Addiction Treatment Programs in the United States.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 32840587.
- Also identified by DOI 10.1001/jama.2020.8969 and PMC identifier PMC6167926.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This study uses simulated patient calls to a random sample of US residential addiction treatment facilities to investigate the availability of opioid agonist treatment (buprenorphine-naloxone) and nonpharmacologic therapies (eg, CBT) for opioid use disorder, and differences by for-profit vs nonprofit center status.